Creatine and Menopause: What the Research Actually Says So Far

You woke up stiffer than you used to.

Not every morning. Not dramatically. But enough times in the last eighteen months that you noticed. The same workout takes longer to recover from. A friend broke a wrist gardening — gardening — and the conversation around her hospital bed was the first time anyone in your circle said the word bone density like it meant something specific. The mirror keeps rearranging itself in small ways you didn't ask for. You haven't said it out loud, but you've started reading.

The problem with most menopause content is that it offers two flavours. One flavour is HRT-or-nothing. The other is a supplement list a mile long, written with the conviction of someone selling each item on it. You're tired of both. You'd like a third option: someone who reads the actual research, doesn't oversell what it says, and treats you like the intelligent adult you are.

This is that article. We've also written our complete guide to creatine for women if you're starting from scratch — start there if the word creatine is still mostly an unknown. This piece focuses on one specific question: what does the most recent research actually say about creatine for women in peri- and post-menopause?

A note up front: the research we'll discuss is emerging. It is not yet recognised as an EU-approved health claim. We will say that every time we cite it. That honesty is the whole point of the article.

Why menopause changes the strength equation

Oestrogen, muscle mass, and bone density

The biology is unromantic but worth knowing. Oestrogen is not just a reproductive hormone — it has receptors in your muscle and bone tissue, and it plays a quiet structural role in maintaining both. As oestrogen declines through perimenopause and stays low after menopause, the maintenance signal weakens. The body becomes less efficient at holding on to muscle mass and less efficient at preserving bone mineral density.

The numbers vary by source, but the meta-analytical consensus is that an untrained adult loses roughly 1% of muscle mass per year after menopause. Bone density follows a similar curve, with the steepest drop in the first five to seven years post-menopause. Neither loss is a disease. Both are physiological. Both respond — to a meaningful degree — to resistance training and adequate protein intake.

Why creatine enters this conversation at all

Creatine is a compound your body already makes and stores in your muscles. It supplies the rapid energy your cells need for short, intense efforts — the second rep, the third sprint, the moment your muscles ask for one more. Women's baseline creatine stores are roughly 70–80% lower than men's, established in the muscle biopsy literature going back two decades.

The menopause transition layers a second loss on top of an already lower baseline. The question that motivates the recent research is straightforward: if a peri- or post-menopausal woman is already training, does adding 3 to 5g of creatine per day change anything measurable about her bones, her muscle, or her strength gains? Until 2023, the honest answer was probably, but the trials are small. In 2023, two papers moved the conversation forward.

What the 2023 research actually found

This section is the spine of the article. Two studies. Both peer-reviewed. Both with caveats.

Chilibeck et al. 2023 — bone density in post-menopausal women

The Chilibeck group ran a 12-month randomised controlled trial in post-menopausal women. The intervention group received creatine plus a structured resistance training programme. The control group received placebo plus the same training. The primary outcome was hip bone mineral density, measured by DXA scan at the start and end of the year.

The finding: the creatine group preserved hip bone mineral density over the 12 months. The placebo group lost it. The effect was statistically significant within the trial cohort.

The caveats matter. The trial was single-site. The sample size was moderate, not large. Funding sources were disclosed and reviewed. The result is an important signal — it is not a population-level conclusion. A single positive trial is the start of a body of evidence, not the end of it.

This is not an EU-approved health claim. Research on creatine and bone health is emerging.

Smith-Ryan et al. 2023 — strength gains in peri- and post-menopausal women

The Smith-Ryan group published a combined cross-sectional analysis and intervention review focused on peri- and post-menopausal cohorts. Across the studies they examined, women supplementing with creatine alongside resistance training showed greater relative strength gains than women doing the same training without supplementation.

The effect was consistent across the included studies. The magnitude varied. The shorter trial windows and heterogeneous cohorts mean the finding is best described as directionally robust, magnitude still being characterised.

This is not an EU-approved health claim.

What these two papers do not claim

It is worth being explicit about what the research does not show, because the gap between encouraging signal and medical recommendation is where most supplement marketing goes wrong.

These papers do not claim that creatine treats the symptoms of menopause. They do not claim it prevents fractures. They do not claim it replaces hormone replacement therapy or any other pharmacological intervention. They do not establish creatine as a treatment for any disease.

What they show is a pattern worth following — and worth more research. PYRRA's position is to mark the signal honestly, not to overstate it.

The one approved claim that still applies

Here is the part of the science that is no longer in question.

The European Food Safety Authority has reviewed the evidence on creatine and high-intensity exercise performance. It is the only health claim about creatine that has been formally authorised for use in the EU and the UK, and it applies to every adult who trains — regardless of life stage.

The verbatim authorised claim, with its mandatory condition of use, is this:

"Creatine increases physical performance in successive bursts of short-term, high intensity exercise. The beneficial effect is obtained with a daily intake of 3g of creatine." (EFSA 2011;9(7):2303)

Why this matters for the menopause reader: if you train — perimenopausal, postmenopausal, any stage — the performance-in-successive-bursts finding applies to you exactly as it applies to a woman in her twenties. The biology of the EFSA claim is not life-stage dependent. The set you push through, the third sprint you finish, the climb you don't stop on — that is what the authorised claim is describing.

It is the one thing we are allowed to say plainly. The rest of the article holds itself to a different, more careful standard — but this part you can take to the bank.

How to take creatine if you're in peri- or post-menopause

The protocol is not different from the general adult population, and that is itself reassuring. There is no menopause-specific dosing. There is no "women's formula." There is no loading phase.

• Dose: 3 to 5g of creatine monohydrate per day. EFSA's authorised performance claim sets 3g as the minimum effective intake; most modern clinical research uses 5g. Either is well-supported. PYRRA's scoop delivers 5g — sit anywhere in that range and you're covered.
• Form: Creatine monohydrate is the only form with a substantial evidence base behind it. Other forms (HCL, ethyl ester, buffered) cost more and have not been shown to outperform monohydrate.
• Timing: Any time of day. Post-workout is practical because you're already drinking water. Morning is fine. With dinner is fine. Consistency matters far more than timing.
• How: Stir it into water, coffee, a smoothie, or yoghurt. Creatine monohydrate is tasteless and dissolves with a quick stir.
• Hydration: Drink water through the day as you normally would — the 2 to 2.5 litre range is a reasonable baseline for most adults.

For the safety side of the conversation — bloating, weight on the scale, kidney questions, hair loss myths — we've covered that in detail in what the research actually says about creatine side effects in women. Read it before you start if any of those questions are sitting at the back of your mind.

A standard caveat applies to creatine as it does to any supplement: if you have a diagnosed kidney condition or take medications that affect kidney function, talk to your GP before starting. Mention creatine if you have routine bloodwork done — it can elevate serum creatinine readings without indicating a problem.

What creatine is not

Because clarity here protects everyone — you, the brand, the reader who finds this article next week — let us be explicit about boundaries.

Creatine is not hormone replacement therapy. It does not replace HRT for any of the indications HRT is prescribed for.

Creatine does not treat hot flashes, night sweats, vasomotor symptoms, sleep disruption, or mood changes associated with menopause. There is no credible research base for any of those claims.

Creatine is not a supplement for menopause. It is a supplement that supports training in any adult — and the reader of this article happens to be in peri- or post-menopause. The framing matters. Creatine is a training tool that the menopausal woman can use, not a menopause treatment that happens to involve a powder.

If the conversation about your menopause needs medical input — and for many women it does — that conversation belongs with a clinician, not a supplement company. We are upfront about what we are and what we are not.

Frequently Asked Questions

Is creatine safe during menopause? For healthy adult women, creatine monohydrate at 3 to 5g per day has been studied extensively and is considered safe. The peri- and post-menopausal cohorts in the recent research did not report adverse safety findings in this range. If you have a pre-existing health condition — particularly involving the kidneys — discuss creatine with your healthcare provider before starting, as you would any new supplement.

Can creatine prevent bone loss in menopause? The Chilibeck 2023 RCT in post-menopausal women found that the creatine + resistance training group preserved hip bone mineral density over 12 months while the placebo + training group lost it. This finding is from emerging research and is not an EU-approved health claim. It is one trial in a developing body of evidence — directionally encouraging, not yet a population-level conclusion.

Does creatine help perimenopausal women? The Smith-Ryan 2023 work examined peri- and post-menopausal cohorts and found greater relative strength gains in women supplementing with creatine alongside resistance training compared with training-only controls. This is emerging research and not an EU-approved health claim. The signal is consistent; the magnitude continues to be characterised in further trials.

How much creatine should a menopausal woman take? 3 to 5g of creatine monohydrate per day. EFSA's authorised performance claim sets 3g as the minimum effective intake; the menopause trials more commonly used 5g, and 5g is what most modern clinical protocols deliver. PYRRA's scoop is 5g. There is no menopause-specific dose. There is no loading phase. Consistency matters more than any other variable.

Is creatine good for women over 50? The EFSA has authorised a separate claim that applies specifically to adults over the age of 55, in the context of resistance training:

"Daily creatine consumption can enhance the effect of resistance training on muscle strength in adults over the age of 55." (EFSA 2016;14(2):4400)

The conditions of use for this claim are 3g of creatine daily in combination with resistance training performed at least three times per week, at an intensity of at least 65 to 75% of one repetition maximum. If you are over 55 and lifting at that intensity at that frequency, this claim was written for you.

Does creatine help with hot flashes? No credible research supports this. There is no mechanistic reason to expect creatine to influence vasomotor symptoms, and no trials have shown an effect. If hot flashes are disrupting your life, that is a conversation for a clinician — not for a creatine canister.

The honest version

The research on creatine and menopause is no longer being whispered. It is being published, peer-reviewed, and slowly built into the broader picture of what supports women's bodies through midlife. Two 2023 trials are not the final word. They are an invitation to look — to follow the literature, to take what is well-established and use it, and to keep an eye on what is emerging.

What is well-established: a daily intake of 3 to 5g of creatine supports physical performance in repeated short, intense efforts. EFSA's authorised claim sets the minimum at 3g; most modern research uses 5g. That holds at twenty-five and it holds at fifty-five.

What is emerging: there are early signals — from peer-reviewed but limited trials — that creatine alongside resistance training may offer something specific to women in peri- and post-menopause around bone density and strength. We will not overstate it. We will continue to read.

You're allowed to take the science that exists without overclaiming it. You're allowed to add a 5g scoop to your morning routine, lift the heavy thing three times this week, and see what happens over a year. You're allowed to do this without anyone selling you a story about transformation.

PYRRA is 100% pure creatine monohydrate, 5g per scoop — the dose used in most modern clinical research. No fillers, no flavourings, no proprietary blends. If that's the version of creatine you've been looking for, join the PYRRA waitlist — we launch soon, and you'll be first to know.

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional for personalised guidance, particularly if you are pregnant, breastfeeding, postmenopausal with a diagnosed condition, or taking prescription medication. The references to Chilibeck et al. 2023 and Smith-Ryan et al. 2023 describe emerging research and are not authorised EU or UK health claims.